SMAD1 and lymphoma: This was found to be correlated with increased expression of SMAD1, a signal transducer protein involved in multiple signaling pathways, by the DNA methylating agent azacytidine, leading to the sensitization of lymphoma cells to genotoxic effect of doxorubicin [26].